CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 729 enrolled
Drug / intervention
Leuprolide acetate Depot Susp. 11.25 mg (Poland), 3.75 mg (Ukraine)drug
Likely dose
Leuprolide acetate Depot Susp. 11.25 mg (Poland), 3.75 mg (Ukraine)from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01078545
NCT01078545N/ACompleted
CompareCT.gov

Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms. International, Multicenter Post-marketing Observational Study.

Abbott·observational·Posted Mar 2, 2010·Updated Jan 16, 2012

In Brief

An observational study evaluating Leuprolide acetate Depot Susp. 11.25 mg (Poland), 3.75 mg (Ukraine) for Advanced Prostate Cancer and Lower Urinary Tract Symptoms. Completed, enrolled 729 participants across 143 sites in 2 countries.

Detailed Summary

The purpose of the study is to determine the influence of GnRH (gonadotropin releasing hormone) analogue - Lucrin Depot 11.25 mg (Lucrin Depot 3.75mg - in Ukraine) administration on intensity of lower urinary tract symptoms (LUTS) in patients with diagnosed locally advanced and/or metastatic prostate cancer and LUTS.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAdvanced Prostate Cancer, Lower Urinary Tract Symptoms
CountriesPoland, Ukraine
CollaboratorsFraktal.com.pl, Med-net.pl

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 2, 2010
Enrollment StartSep 1, 2008
Primary CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 16.3 years ago

Interventions

Leuprolide acetate Depot Susp. 11.25 mg (Poland), 3.75 mg (Ukraine)drug

Leuprolide acetate 11.25 mg every 3 months sc or im, number of injections during the trial - 5 in Poland, Leuprolide acetate 3.75 mg every 1 month sc or im, number of injections during the trial - 12 in Ukraine.